AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 2024-08-05 17:05:27 | 12,929,322 0 | 12,929,322 | Form 13D |
Atlas Venture Opportunity Fund II L.P. Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 2024-11-14 16:30:11 | 4,869,681 0 | 4,869,681 | Form 13G |
Atlas Venture Fund XI L.P. 10% Owner | 2024-11-14 16:30:11 | 4,869,681 0 | 4,869,681 | Form 13G |
Atlas Venture Fund XI L.P. Atlas Venture Opportunity Fund I L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Associates Opportunity I LLC Atlas Venture Associates Opportunity I L.P. 10% Owner | 2024-11-14 16:30:11 | 4,869,681 0 | 4,869,681 | Form 13G |
Grant Julie Papanek Director | 2023-03-03 17:48:33 | 0 2,880,761 | 2,880,761 | Form 4 |
Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 2022-11-02 16:15:55 | 2,548,403 0 | 2,548,403 | Form 13D |
Blackman Samuel C. HEAD OF R&D | 2024-12-12 16:06:23 | 1,034,015 1,000,000 | 2,034,015 | Form 4 |
Atlas Venture Opportunity Fund I L.P. 10% Owner | 2022-07-06 16:42:35 | 991,396 0 | 991,396 | Form 4 |
Bender Jeremy CHIEF EXECUTIVE OFFICER | 2025-01-31 16:36:18 | 473,000 0 | 473,000 | Form 4 |
York Charles N II COO, CFO AND SECRETARY | 2025-01-31 16:38:23 | 268,000 0 | 268,000 | Form 4 |
Dubow Adam GENERAL COUNSEL | 2025-01-31 16:33:58 | 149,000 0 | 149,000 | Form 4 |
Ramasastry Saira Director | 2024-06-21 19:17:18 | 40,485 0 | 40,485 | Form 4 |
Becker Daniel J. Director | 2023-06-26 19:15:02 | 37,500 0 | 37,500 | Form 4 |
Nicholson Garry A Director | 2024-05-28 18:27:04 | 32,335 0 | 32,335 | Form 4 |
Gladstone Michael Director | 2024-05-28 18:17:45 | 32,335 0 | 32,335 | Form 4 |
Josey John A. Director | 2024-05-28 18:24:17 | 32,335 0 | 32,335 | Form 4 |
Grossman William Director | 2024-05-28 18:44:36 | 32,335 0 | 32,335 | Form 4 |
Dable Habib J Director | 2024-05-28 18:13:59 | 32,335 0 | 32,335 | Form 4 |
Holles Natalie C. Director | 2024-05-28 18:21:04 | 32,335 0 | 32,335 | Form 4 |
Garland J. Scott Director | 2024-05-28 18:48:07 | 32,335 0 | 32,335 | Form 4 |
TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 2023-02-03 17:06:04 | 0 0 | 0 | Form 13G |